spacer
home > ebr > summer 2019 > closer to the cure
PUBLICATIONS
European Biopharmaceutical Review

Closer to the Cure

Cancer has always been with us. For most of history, it was entirely untreatable; now, two out of three Americans with invasive cancer survive for at least five years. Overall cancer survival rates in the UK have doubled over the past 40 years; now, most people diagnosed with cancer live for at least 10 more years. Though a lot of progress has been made, it is uneven, and the next set of breakthroughs will require accepting a high risk of failure. We will need to look beyond incremental change towards potential cures.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Christian Rommel is Roche’s Global Head of Pharma Research and Early Development (pRED) Oncology. Before that, he led the pRED Oncology Discovery group from 2014 to 2018. Previous to joining Roche, he held the positions of Vice President of External Research and Development and Vice President of Research Oncology at Amgen. Christian served as Chief Scientific Officer at a private biotechnology company (Intellikine) from its inception to acquisition by Takeda in 2011. Previously, Christian was Head of Target Research at Merck Serono from 2000 to 2007. Over the course of his career, Christian authored more than 70 publications and was an inventor or co-inventor of 18 patents. Christian received his PhD in molecular oncology/signal transduction from the Max Planck Institute in Berlin, Germany, and the Institute of Medical Virology at the University of Zurich, Switzerland.
spacer
Christian Rommel
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

White Papers

Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands

West Pharmaceutical Services, Inc.

The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement